Jane Street Group, LLC Ironwood Pharmaceuticals Inc Call Options Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 15, 2022	BUY	$10.86 - $13.95 $508,248 - $652,860	46,800 Added 146.71%	78,700 $918,000
Q3 2021 Nov 16, 2021	SELL	$11.92 - $13.92 $222,904 - $260,304	-18,700 Reduced 36.96%	31,900 $417,000
Q2 2021 Aug 16, 2021	BUY	$10.16 - $13.11 $378,968 - $489,003	37,300 Added 280.45%	50,600 $651,000
Q1 2021 May 18, 2021	SELL	$9.04 - $11.86 $98,535 - $129,274	-10,900 Reduced 45.04%	13,300 $149,000
Q4 2020 Feb 17, 2021	BUY	$9.05 - $12.2 $219,010 - $295,240	24,200 New	24,200 $276,000

237

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $706M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.